Auxilium empowers entrepreneurs and innovators with the resources, network, education, and support needed to grow impactful, thriving ventures. Opening in downtown Worcester in Q2 2025, Auxilium will feature both an innovation studio and a startup accelerator, each offering programming, mentoring and more tailored to the unique needs of businesses at different stages of growth.

The Venture Forum is a startup community committed to helping entrepreneurs launch and scale their business in Central MA. We connect entrepreneurs and aspiring entrepreneurs with resources, mentors and educational opportunities necessary to drive entrepreneurial success.

Premier digital angel investor group in western New England, investing in syndicated deals with a variety of financial instruments

Advisor in guiding startups to their first $10 million in revenue through a unique, non dilutive investment model

Provide ongoing advice on an as needed basis

Implemented development program for Prismic's core drug asset and integration with the new BioSciences division.

Prismic was acquired by FSD Pharma Inc. in June 2019. The company was focused on the development of innovative prescription drugs with unique safety profiles to address pain and inflammation. The company acquired the worldwide rights (with the exception of Italy and Spain) to a proprietary form of palmitoylethanolamide (micro-PEA) from which its initial drug candidate, PP101, was formulated.

Focused on an out licensing project for a specific client, including researching potential partners, attending conferences and industry events

Nashoba North is Maine sleepaway summer camp that offers a traditional camp experience for 190 boys and girls ages 7 to 17.

Joined the company as the seventh full time employee with responsibilities in the area of new business initiatives and special projects. Played a lead role in the completion of three co-promotion agreements that resulted in > $5 million in upfront payments.

Established company to provide business development services for smaller pharmaceutical companies primarily focused on seeking distribution partners in markets outside of North America and the European Union• Successfully completed out-licensing deals for clients in Eastern Europe, Australia, and Israel that resulted in upfront and milestone payments in > $1.5 million

Established company as a new venture to market nutritional products to target patient population directly and through distributors. Sold lead product to existing distributor.

Established branch office in Miami, FL to manage company operations in South America and the Caribbean, including distributors in Chile and Argentina and oversee manufacturing partner in Colombia.

Established first corporate office in the United States and launched a new product line with Year 1 sales of > $200,000.